CanBas Co.,Ltd.
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
4575 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 沼津市大手町二丁目２番１号
- Website:
- https://www.canbas.co.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CanBas Co., Ltd. is a clinical-stage biopharmaceutical company dedicated to the research and development of novel therapeutics for cancer patients. The company focuses on discovering and developing innovative oncology drugs, particularly in the field of immuno-oncology, that target the cell cycle. CanBas utilizes a proprietary screening system to advance its drug pipeline, which includes the clinical-stage candidate CBP501, a calmodulin-modulating peptide. A key objective of its research is to create anticancer treatments with fewer side effects.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-29 08:46 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | ||
| 2025-09-29 08:46 |
Annual Report
有価証券報告書－第26期(2024/07/01－2025/06/30)
|
Japanese | 576.6 KB | ||
| 2025-02-13 07:55 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | ||
| 2025-02-13 07:54 |
Interim Report
半期報告書－第26期(2024/07/01－2025/06/30)
|
Japanese | 160.4 KB | ||
| 2024-09-30 08:04 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.7 KB | ||
| 2024-09-27 08:21 |
Governance Information
内部統制報告書－第25期(2023/07/01－2024/06/30)
|
Japanese | 21.7 KB | ||
| 2024-09-27 08:21 |
Registration Form
確認書
|
Japanese | 8.1 KB | ||
| 2024-09-27 08:20 |
Annual Report
有価証券報告書－第25期(2023/07/01－2024/06/30)
|
Japanese | 637.2 KB | ||
| 2024-05-10 08:16 |
Report Publication Announcement
確認書
|
Japanese | 8.1 KB | ||
| 2024-05-10 08:16 |
Quarterly Report
四半期報告書－第25期第3四半期(2024/01/01－2024/03/31)
|
Japanese | 134.6 KB | ||
| 2024-02-09 08:13 |
Report Publication Announcement
確認書
|
Japanese | 8.0 KB | ||
| 2024-02-09 08:12 |
Interim Report
四半期報告書－第25期第2四半期(2023/10/01－2023/12/31)
|
Japanese | 163.0 KB | ||
| 2023-11-10 08:00 |
Regulatory News Service
確認書
|
Japanese | 8.0 KB | ||
| 2023-11-10 07:51 |
Quarterly Report
四半期報告書－第25期第1四半期(2023/07/01－2023/09/30)
|
Japanese | 134.0 KB | ||
| 2023-09-27 08:08 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.4 KB |
Automate Your Workflow. Get a real-time feed of all CanBas Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CanBas Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CanBas Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
